Cargando…
Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency
Monogenic and polygenic mutations are important contributors in patients suffering from epilepsy, including metabolic epilepsies which are inborn errors of metabolism with a good respond to specific dietetic treatments. Heterozygous variation in solute carrier family 2, facilitated glucose transport...
Autores principales: | Daci, Armond, Bozalija, Adnan, Jashari, Fisnik, Krasniqi, Shaip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796071/ https://www.ncbi.nlm.nih.gov/pubmed/29303961 http://dx.doi.org/10.3390/ijms19010122 |
Ejemplares similares
-
Pharmacotherapy Evaluation and Utilization in Coronary Artery Bypass Grafting Patients in Kosovo during the Period 2016-2017
por: Daci, Armond, et al.
Publicado: (2018) -
Role of the Angiotensin Pathway and its Target Therapy in Epilepsy Management
por: Krasniqi, Shaip, et al.
Publicado: (2019) -
Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients
por: Daci, Armond, et al.
Publicado: (2015) -
Tuberculosis Treatment Adherence of Patients in Kosovo
por: Krasniqi, Shaip, et al.
Publicado: (2017) -
Association between coenzyme Q(10) and glucose transporter (GLUT1) deficiency
por: Yubero, Delia, et al.
Publicado: (2014)